(Press-News.org) A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for neurodegenerative diseases. This finding, published in the July 18 issue of Cell Reports, offers new hope in the battle against a foe that until now has always proved fatal.
Prion diseases include Creuzfeldt-Jakob disease and fatal familial insomnia. Unlike other transmissible diseases, the infectious agent is not a virus or bacteria, but an abnormally shaped prion protein. Scientists believe it self-replicates by binding to normal prion proteins and forcing them to change shape to become an abnormal, and thus diseased, protein.
"Once heretical, the notion that proteins alone can act as self-propagating infectious agent is now becoming accepted as a new paradigm in biology and medicine. However, the mechanism by which prion protein changes its shape remains largely unknown and highly controversial, hindering efforts to develop drugs for prion diseases," said Witold Surewicz, PhD, professor of physiology and biophysics and senior author of the study. "A heated debate continues as to which part of the prion protein undergoes the change and what is the three-dimensional structure of the infectious form of the protein."
The researchers generated a variant of prion protein designed to stabilize the normal shape of one specific part of the protein. They accomplished this goal by replacing just one out of more than 200 amino acid residues, the building blocks of the protein. In a series of experiments, the researchers found that the modified prion protein was highly resistant to changing its shape. In other words, this approach may be successful in blocking the coercive action of the abnormal prion protein.
The team then created transgenic mice that produced this "superstable" human prion protein and infected them with Creutzfeldt-Jakob disease prions. The mice did eventually develop symptoms, but the signs did not emerge for more than a year – in fact, it took about 400 days. In contrast, mice without the modified prion protein showed symptoms within 260 days.
"Our discovery that a tailor-made mutation in one specific region of prion protein can prevent it from changing shape to a disease-associated conformation helps resolve the ongoing major controversy in the field regarding the mechanism by which infectious prions self-replicate," said Qingzhong Kong, PhD, associate professor of pathology and first author on the paper.
With no effective treatments currently available for these fatal diseases, this finding has also important implications for the development of new drugs. It suggests a novel pharmacologic strategy in which scientists can either identify or design a molecule that binds to prion protein and stabilizes its normal shape, thereby preventing propagation of the disease.
###
The study is a result of a collaborative effort between the laboratories of Surewicz, Kong, Pierluigi Gambetti, MD, professor of pathology at Case Western Reserve School of Medicine, and Frank Sönnichsen, PhD, professor at the University of Kiel in Germany.
The study was supported by National Institute of Neurological Disorders and Stroke and National Institute of Aging grants including: NSO44158, NS038604, NS052319, and AG014359.
About Case Western Reserve University School of Medicine
Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.
Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research-oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."
The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu
New approach to protecting prion protein from altering shape
Important step toward pharmacologic development of treatment for fatal brain disorders
2013-07-18
ELSE PRESS RELEASES FROM THIS DATE:
Scientists develop new way to measure cumulative effect of head hits in football
2013-07-18
WINSTON-SALEM, N.C., July 18, 2013 -- Scientists at Wake Forest Baptist Medical Center have developed a new way to measure the cumulative effect of impacts to the head incurred by football players.
The metric, called Risk Weighted Cumulative Exposure (RWE), can capture players' exposure to the risk of concussion over the course of a football season by measuring the frequency and magnitude of all impacts, said senior author of the study Joel Stitzel, Ph.D., chair of biomedical engineering at Wake Forest Baptist and associate head of the Virginia Tech-Wake Forest University ...
Emerging importance of computerized cognitive testing -- new therapies for dementia
2013-07-18
Boston, MA – Computerized cognitive testing is increasingly playing a key role in therapy development for dementia and Alzheimer's disease. This week at the Alzheimer's Association International Conference, Keith Wesnes Ph.D., Practice Leader of Bracket and founder of the CDR System™, discussed new data for novel therapies at two poster presentations at the Alzheimer's Association International Conference.
Poster Title: Cognitive evidence in Alzheimer's disease patients that compromised hippocampal neurogenesis is related both to APOE4 status and CSF Abeta42
This presentation ...
New treatment offers hope for short-bowel syndrome patients
2013-07-18
Bethesda, MD (July 18, 2013) — A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal failure who are reliant on intravenous nutrition, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Patients with this relatively rare condition experience massive bowel loss and are unable to absorb nutrients, vitamins and water from digested foods. They rely on parenteral nutrition, or intravenous feeding, to deliver their daily nutrients.
"Short-bowel ...
Registration is Open for First Ever Mushrooms and Health Summit
2013-07-18
Registration is now open for the Mushrooms and Health Summit held at the Mayflower Renaissance hotel in Washington D.C. on September 9-10, 2013. The meeting is of interest to scientists, writers and researchers looking to learn and discuss the unique and comprehensive examination of the global research that links mushrooms to today's and future health issues.
A world-class scientific event
Learn from the world's top scientists, researchers and nutrition experts who will provide a broad range of perspectives and facilitate discussions around mushrooms from spore to spoon. ...
Computer system automatically generates TCP congestion-control algorithms
2013-07-18
CAMBRIDGE, Mass- TCP, the transmission control protocol, is one of the core protocols governing the Internet: If counted as a computer program, it's the most widely used program in the world.
One of TCP's main functions is to prevent network congestion by regulating the rate at which computers send data. In the last 25 years, engineers have made steady improvements to TCP's congestion-control algorithms, resulting in several competing versions of the protocol: Many Windows computers, for instance, run a version called Compound TCP, while Linux machines run a version called ...
Consensus statement on pediatric arrhythmias released by ESC and AEPC
2013-07-18
Sophia Antipolis, 18 July 2013: A joint consensus statement on the treatment of paediatric arrhythmias has been released by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) and the Association for European Paediatric and Congenital Cardiology (AEPC).
"Pharmacological and non-pharmacological therapy for arrhythmias in the paediatric population" was published in EP-Europace.1
Consensus statements have been published on arrhythmias in adults but this is the first European statement concerning the diagnosis and management of paediatric ...
Electronic health records help fight vaccine-preventable diseases, Columbia Nursing study finds
2013-07-18
Using an Electronic Health Record (EHR) system to automate the immunization data shared between health providers and public health agencies enables physicians to assist individual patients faster and more effectively, while also providing more immediate, cohesive community data to the agencies tasked with promoting public health.
Those are the findings of a new study conducted by researchers from Columbia University School of Nursing and partner institutions. The researchers also found that automated reporting reduced the lag time historically associated with data submitted ...
Study identifies a simple way to reduce healthcare costs
2013-07-18
MAYWOOD, Il. - A study led by a Loyola University Medical Center ENT physician provides a case study of a simple action that can reduce healthcare costs without compromising care.
Matthew Kircher, MD, and colleagues examined one of the costs associated with surgery to remove a type of cyst, called a cholesteatoma, from the middle ear. Otologists routinely send specimens to the pathology lab, but the study found this doesn't appear to be necessary.
The study found that in 178 cases involving seven otologists, there was virtually perfect agreement between the otologists' ...
Obesity and asthma: Study finds a link in the genes
2013-07-18
BUFFALO, N.Y. — Genes linked to chronic inflammation in asthma may be more active in people who are obese, according to new research that uncovers several biological ties between obesity and asthma.
"Our findings point the way to the management of asthma in the obese through simple weight reduction," said first author Paresh Dandona, MD, PhD, SUNY Distinguished Professor and Chief of Endocrinology, Diabetes and Metabolism at the University at Buffalo.
The research appeared online June 26 in the journal Obesity and involved two related studies: A comparative study between ...
Epoetin alfa reduces anemia in breast cancer patients with no negative impact on survival
2013-07-18
In patients with high-risk breast cancer, addition of the erythropoiesis-stimulating agent (ESA) epoetin alfa to the chemotherapy regimen may help avoid the decrease in hemoglobin levels and resulting anemia often seen in these patients and does not negatively affect relapse-free (RFS) or overall survival (OS). However, it can increase the risk of thrombotic events, according to a study published July 17 in the Journal of the National Cancer Institute.
To investigate the safety and efficacy of epoetin alfa, Volker Moebus, M.D., of the Department of Gynecology and Obstetrics, ...
LAST 30 PRESS RELEASES:
Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health
Researchers improve chemical reaction that underpins products from foods to fuels
Texas Tech to develop semiconductor power devices through $6 million grant
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
Hot Schrödinger cat states created
How cells repair their power plants
Oxygen is running low in inland waters—and humans are to blame
ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain
Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity
How a small number of mutations can fuel outbreaks of western equine encephalitis virus
Exposure to wildfire smoke linked with worsening mental health conditions
Research uncovers hidden spread of one of the most common hospital-associated infections
Many older adults send their doctors portal messages, but who pays?
Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits
Gender inequity in institutional leadership roles in US academic medical centers
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Rare combination of ovarian tumors found in one patient
AI-driven clinical recommendations may aid physician decision making to improve quality of care
Artificial intelligence has potential to aid physician decisions during virtual urgent care
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
New study reveals polymers with flawed fillers boost heat transfer in plastics
Signs identified that precede sudden arrhythmic death syndrome in young people
Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance
Pre-eclampsia is associated with earlier onset and higher incidence of cardiovascular risk factors
Warwick astronomers discover doomed pair of spiralling stars on our cosmic doorstep
Soil conditions significantly increase rainfall in world’s megastorm hotspots
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma
Planetary health diet and mediterranean diet associated with similar survival and sustainability benefits
Singapore launches national standard to validate antimicrobial disinfectant products
Molecular stool test could improve detection of tuberculosis in adults with HIV
[Press-News.org] New approach to protecting prion protein from altering shapeImportant step toward pharmacologic development of treatment for fatal brain disorders